The UK's largest and fastest-growing MenB outbreak in recent years has highlighted the urgent need for protection among young people, particularly students who face a heightened risk of contracting this serious infection. This autumn, first-year university students and sixth formers will be eligible to receive a free Meningitis B (MenB) vaccine as part of a new campaign to safeguard vulnerable groups.
The Kent outbreak in March saw 29 confirmed or suspected cases and two deaths within a matter of weeks, sparking concerns over the UK's public health. According to NHS England, first-year university students have a risk about seven times higher than young people of a similar age who do not attend university. The NHS states that those born between 1 September 2007 and 31 August 2008 are eligible for the vaccine, as well as students under the age of 25 heading to a residential college or university for the first time this autumn.
The MenB vaccine is available free to approximately one million young people in England. This includes international students, those from other parts of the UK or abroad studying in England, and individuals born on or after 21 July 2001 who are embarking on their first university or residential further education college experience this autumn.
Meningitis B can cause severe and life-threatening conditions, including inflammation of the brain lining (meningitis) and blood poisoning (sepsis). The consequences can be devastating, with potential outcomes ranging from life-changing disabilities to fatalities. However, the MenB vaccine is a safe and effective preventative measure that does not contain live bacteria and cannot cause meningitis.
The MenB vaccine requires two doses, administered at least 28 days apart, for optimal protection. This targeted campaign aims to safeguard those at greater risk due to factors like increased social mixing and shared living arrangements common in student environments, as well as those who missed out on routine vaccination during infancy.